study_name	subject_id	Sample Source ID	target_condition	target_condition_ontology_term_id	control	control_ontology_term_id	country	country_ontology_term_id	body_site	body_site_ontology_term_id	age_group	age_group_ontology_term_id	age_max	age_min	age_years	antibiotics_current_use	curator	disease	disease_ontology_term_id	dna_extraction_kit	median_read_length	minimum_read_length	ncbi_accession	number_bases	number_reads	pmid	sequencing_platform	sex	sex_ontology_term_id	treatment	treatment_ontology_term_id	westernized	package	last_updated
Castro-NallarE_2015	ES_001	ES_001	Schizophrenia	NCIT:C3362	Case	NCIT_C49152	United States	NCIT:C17234	oral cavity	UBERON:0000167	Adult	NCIT:C49685	36	36	36	NA	Paolo_Manghi	Schizophrenia	NCIT:C3362	MoBio	101	101	SRR1519058	9800639333	97036033	26336637	IlluminaHiSeq	Female	NCIT:C16576	second generation antipsychotic	CHEBI:65191	Yes	cMD	2025-07-13 16:10:43.046834
Castro-NallarE_2015	ES_007	ES_007	Schizophrenia	NCIT:C3362	Case	NCIT_C49152	United States	NCIT:C17234	oral cavity	UBERON:0000167	Adult	NCIT:C49685	40	40	40	NA	Paolo_Manghi	Schizophrenia	NCIT:C3362	MoBio	101	101	SRR1519059	9848414555	97509055	26336637	IlluminaHiSeq	Male	NCIT:C20197	second generation antipsychotic	CHEBI:65191	Yes	cMD	2025-07-13 16:10:43.046834
Castro-NallarE_2015	ES_010	ES_010	Schizophrenia	NCIT:C3362	Case	NCIT_C49152	United States	NCIT:C17234	oral cavity	UBERON:0000167	Adult	NCIT:C49685	37	37	37	NA	Paolo_Manghi	Type 2 Diabetes Mellitus;Schizophrenia	NCIT:C26747;NCIT:C3362	MoBio	101	101	SRR1519060	7381832854	73087454	26336637	IlluminaHiSeq	Female	NCIT:C16576	second generation antipsychotic	CHEBI:65191	Yes	cMD	2025-07-13 16:10:43.046834
Castro-NallarE_2015	ES_014	ES_014	Schizophrenia	NCIT:C3362	Case	NCIT_C49152	United States	NCIT:C17234	oral cavity	UBERON:0000167	Adult	NCIT:C49685	28	28	28	NA	Paolo_Manghi	Schizophrenia	NCIT:C3362	MoBio	101	101	SRR1519061	7823024488	77455688	26336637	IlluminaHiSeq	Male	NCIT:C20197	second generation antipsychotic	CHEBI:65191	Yes	cMD	2025-07-13 16:10:43.046834
Castro-NallarE_2015	ES_017	ES_017	Schizophrenia	NCIT:C3362	Case	NCIT_C49152	United States	NCIT:C17234	oral cavity	UBERON:0000167	Adult	NCIT:C49685	39	39	39	NA	Paolo_Manghi	Schizophrenia	NCIT:C3362	MoBio	101	101	SRR1519071	6925292048	68567248	26336637	IlluminaHiSeq	Female	NCIT:C16576	Dopamine Antagonist	NCIT:C66883	Yes	cMD	2025-07-13 16:10:43.046834
Castro-NallarE_2015	ES_019	ES_019	Schizophrenia	NCIT:C3362	Case	NCIT_C49152	United States	NCIT:C17234	oral cavity	UBERON:0000167	Adult	NCIT:C49685	32	32	32	NA	Paolo_Manghi	Schizophrenia	NCIT:C3362	MoBio	101	101	SRR1519072	6656786679	65908779	26336637	IlluminaHiSeq	Male	NCIT:C20197	second generation antipsychotic	CHEBI:65191	Yes	cMD	2025-07-13 16:10:43.046834
Castro-NallarE_2015	ES_024	ES_024	Schizophrenia	NCIT:C3362	Case	NCIT_C49152	United States	NCIT:C17234	oral cavity	UBERON:0000167	Adult	NCIT:C49685	34	34	34	NA	Paolo_Manghi	Schizophrenia	NCIT:C3362	MoBio	101	101	SRR1519073	9727118403	96308103	26336637	IlluminaHiSeq	Male	NCIT:C20197	Dopamine Antagonist;second generation antipsychotic	NCIT:C66883;CHEBI:65191	Yes	cMD	2025-07-13 16:10:43.046834
Castro-NallarE_2015	ES_043	ES_043	Schizophrenia	NCIT:C3362	Case	NCIT_C49152	United States	NCIT:C17234	oral cavity	UBERON:0000167	Adult	NCIT:C49685	27	27	27	NA	Paolo_Manghi	Schizophrenia	NCIT:C3362	MoBio	101	101	SRR1519075	7719797236	76433636	26336637	IlluminaHiSeq	Male	NCIT:C20197	Phenylpiperidine derivative (substance);second generation antipsychotic	48070003;CHEBI:65191	Yes	cMD	2025-07-13 16:10:43.046834
Castro-NallarE_2015	ES_046	ES_046	Schizophrenia	NCIT:C3362	Case	NCIT_C49152	United States	NCIT:C17234	oral cavity	UBERON:0000167	Adult	NCIT:C49685	40	40	40	NA	Paolo_Manghi	Schizophrenia	NCIT:C3362	MoBio	101	101	SRR1519076	5117234892	50665692	26336637	IlluminaHiSeq	Female	NCIT:C16576	Dopamine Antagonist	NCIT:C66883	Yes	cMD	2025-07-13 16:10:43.046834
Castro-NallarE_2015	ES_048	ES_048	Schizophrenia	NCIT:C3362	Case	NCIT_C49152	United States	NCIT:C17234	oral cavity	UBERON:0000167	Adult	NCIT:C49685	41	41	41	NA	Paolo_Manghi	Schizophrenia	NCIT:C3362	MoBio	101	101	SRR1519077	5480286967	54260267	26336637	IlluminaHiSeq	Male	NCIT:C20197	Dopamine Antagonist	NCIT:C66883	Yes	cMD	2025-07-13 16:10:43.046834
Castro-NallarE_2015	ES_069	ES_069	Schizophrenia	NCIT:C3362	Study Control	NCIT_C142703	United States	NCIT:C17234	oral cavity	UBERON:0000167	Adult	NCIT:C49685	59	59	59	No	Paolo_Manghi	Healthy	NCIT:C115935	MoBio	101	101	SRR1518393;SRR1518410	14408724539	142660639	26336637	IlluminaHiSeq	Female	NCIT:C16576	NA	NA	Yes	cMD	2025-07-13 16:10:43.046834
Castro-NallarE_2015	ES_080	ES_080	Schizophrenia	NCIT:C3362	Case	NCIT_C49152	United States	NCIT:C17234	oral cavity	UBERON:0000167	Adult	NCIT:C49685	31	31	31	NA	Paolo_Manghi	Type 2 Diabetes Mellitus;Schizophrenia	NCIT:C26747;NCIT:C3362	MoBio	101	101	SRR1519078	6842557090	67748090	26336637	IlluminaHiSeq	Male	NCIT:C20197	Dopamine Antagonist	NCIT:C66883	Yes	cMD	2025-07-13 16:10:43.046834
Castro-NallarE_2015	ES_088	ES_088	Schizophrenia	NCIT:C3362	Study Control	NCIT_C142703	United States	NCIT:C17234	oral cavity	UBERON:0000167	Adult	NCIT:C49685	29	29	29	No	Paolo_Manghi	Healthy	NCIT:C115935	MoBio	101	101	SRR1518476	4702605551	46560451	26336637	IlluminaHiSeq	Male	NCIT:C20197	NA	NA	Yes	cMD	2025-07-13 16:10:43.046834
Castro-NallarE_2015	ES_089	ES_089	Schizophrenia	NCIT:C3362	Study Control	NCIT_C142703	United States	NCIT:C17234	oral cavity	UBERON:0000167	Adult	NCIT:C49685	29	29	29	No	Paolo_Manghi	Healthy	NCIT:C115935	MoBio	101	101	SRR1518536	5168179797	51170097	26336637	IlluminaHiSeq	Female	NCIT:C16576	NA	NA	Yes	cMD	2025-07-13 16:10:43.046834
Castro-NallarE_2015	ES_095	ES_095	Schizophrenia	NCIT:C3362	Study Control	NCIT_C142703	United States	NCIT:C17234	oral cavity	UBERON:0000167	Adult	NCIT:C49685	32	32	32	No	Paolo_Manghi	Healthy	NCIT:C115935	MoBio	101	101	SRR1518998	2996769889	29670989	26336637	IlluminaHiSeq	Male	NCIT:C20197	NA	NA	Yes	cMD	2025-07-13 16:10:43.046834
Castro-NallarE_2015	ES_099	ES_099	Schizophrenia	NCIT:C3362	Study Control	NCIT_C142703	United States	NCIT:C17234	oral cavity	UBERON:0000167	Adult	NCIT:C49685	48	48	48	No	Paolo_Manghi	Healthy	NCIT:C115935	MoBio	101	101	SRR1519031	4439642658	43956858	26336637	IlluminaHiSeq	Male	NCIT:C20197	NA	NA	Yes	cMD	2025-07-13 16:10:43.046834
Castro-NallarE_2015	ES_104	ES_104	Schizophrenia	NCIT:C3362	Study Control	NCIT_C142703	United States	NCIT:C17234	oral cavity	UBERON:0000167	Adult	NCIT:C49685	46	46	46	No	Paolo_Manghi	Healthy	NCIT:C115935	MoBio	101	101	SRR1519044	3739194528	37021728	26336637	IlluminaHiSeq	Male	NCIT:C20197	NA	NA	Yes	cMD	2025-07-13 16:10:43.046834
Castro-NallarE_2015	ES_106	ES_106	Schizophrenia	NCIT:C3362	Study Control	NCIT_C142703	United States	NCIT:C17234	oral cavity	UBERON:0000167	Adult	NCIT:C49685	29	29	29	No	Paolo_Manghi	Healthy	NCIT:C115935	MoBio	101	101	SRR1519045	3894789371	38562271	26336637	IlluminaHiSeq	Female	NCIT:C16576	NA	NA	Yes	cMD	2025-07-13 16:10:43.046834
Castro-NallarE_2015	ES_107	ES_107	Schizophrenia	NCIT:C3362	Study Control	NCIT_C142703	United States	NCIT:C17234	oral cavity	UBERON:0000167	Adult	NCIT:C49685	27	27	27	No	Paolo_Manghi	Healthy	NCIT:C115935	MoBio	101	101	SRR1519046	5185647141	51343041	26336637	IlluminaHiSeq	Female	NCIT:C16576	NA	NA	Yes	cMD	2025-07-13 16:10:43.046834
Castro-NallarE_2015	ES_108	ES_108	Schizophrenia	NCIT:C3362	Case	NCIT_C49152	United States	NCIT:C17234	oral cavity	UBERON:0000167	Adult	NCIT:C49685	37	37	37	No	Paolo_Manghi	Schizophrenia	NCIT:C3362	MoBio	101	101	SRR1519079	10623057891	105178791	26336637	IlluminaHiSeq	Male	NCIT:C20197	NA	NA	Yes	cMD	2025-07-13 16:10:43.046834
Castro-NallarE_2015	ES_110	ES_110	Schizophrenia	NCIT:C3362	Study Control	NCIT_C142703	United States	NCIT:C17234	oral cavity	UBERON:0000167	Adult	NCIT:C49685	46	46	46	No	Paolo_Manghi	Healthy	NCIT:C115935	MoBio	101	101	SRR1519047	5858991820	58009820	26336637	IlluminaHiSeq	Male	NCIT:C20197	NA	NA	Yes	cMD	2025-07-13 16:10:43.046834
Castro-NallarE_2015	ES_114	ES_114	Schizophrenia	NCIT:C3362	Study Control	NCIT_C142703	United States	NCIT:C17234	oral cavity	UBERON:0000167	Adult	NCIT:C49685	28	28	28	No	Paolo_Manghi	Healthy	NCIT:C115935	MoBio	101	101	SRR1519048	4166963060	41257060	26336637	IlluminaHiSeq	Female	NCIT:C16576	NA	NA	Yes	cMD	2025-07-13 16:10:43.046834
Castro-NallarE_2015	ES_116	ES_116	Schizophrenia	NCIT:C3362	Case	NCIT_C49152	United States	NCIT:C17234	oral cavity	UBERON:0000167	Adult	NCIT:C49685	37	37	37	No	Paolo_Manghi	Schizophrenia	NCIT:C3362	MoBio	101	101	SRR1519080	3602407703	35667403	26336637	IlluminaHiSeq	Female	NCIT:C16576	NA	NA	Yes	cMD	2025-07-13 16:10:43.046834
Castro-NallarE_2015	ES_132	ES_132	Schizophrenia	NCIT:C3362	Case	NCIT_C49152	United States	NCIT:C17234	oral cavity	UBERON:0000167	Adult	NCIT:C49685	36	36	36	NA	Paolo_Manghi	Schizophrenia	NCIT:C3362	MoBio	101	101	SRR1519082	4208523954	41668554	26336637	IlluminaHiSeq	Male	NCIT:C20197	Dopamine Antagonist;Phenylpiperidine derivative (substance)	NCIT:C66883;48070003	Yes	cMD	2025-07-13 16:10:43.046834
Castro-NallarE_2015	ES_137	ES_137	Schizophrenia	NCIT:C3362	Case	NCIT_C49152	United States	NCIT:C17234	oral cavity	UBERON:0000167	Adult	NCIT:C49685	29	29	29	No	Paolo_Manghi	Type 2 Diabetes Mellitus;Schizophrenia	NCIT:C26747;NCIT:C3362	MoBio	101	101	SRR1519083	6029544662	59698462	26336637	IlluminaHiSeq	Female	NCIT:C16576	NA	NA	Yes	cMD	2025-07-13 16:10:43.046834
Castro-NallarE_2015	ES_147	ES_147	Schizophrenia	NCIT:C3362	Case	NCIT_C49152	United States	NCIT:C17234	oral cavity	UBERON:0000167	Adult	NCIT:C49685	27	27	27	No	Paolo_Manghi	Crohn Disease;Schizophrenia	NCIT:C2965;NCIT:C3362	MoBio	101	101	SRR1519084	4645589940	45995940	26336637	IlluminaHiSeq	Female	NCIT:C16576	NA	NA	Yes	cMD	2025-07-13 16:10:43.046834
Castro-NallarE_2015	ES_158	ES_158	Schizophrenia	NCIT:C3362	Study Control	NCIT_C142703	United States	NCIT:C17234	oral cavity	UBERON:0000167	Adult	NCIT:C49685	27	27	27	No	Paolo_Manghi	Healthy	NCIT:C115935	MoBio	101	101	SRR1519049	5186404540	51350540	26336637	IlluminaHiSeq	Female	NCIT:C16576	NA	NA	Yes	cMD	2025-07-13 16:10:43.046834
Castro-NallarE_2015	ES_207	ES_207	Schizophrenia	NCIT:C3362	Study Control	NCIT_C142703	United States	NCIT:C17234	oral cavity	UBERON:0000167	Adult	NCIT:C49685	26	26	26	No	Paolo_Manghi	Healthy	NCIT:C115935	MoBio	101	101	SRR1519050	3749779227	37126527	26336637	IlluminaHiSeq	Female	NCIT:C16576	NA	NA	Yes	cMD	2025-07-13 16:10:43.046834
Castro-NallarE_2015	ES_208	ES_208	Schizophrenia	NCIT:C3362	Study Control	NCIT_C142703	United States	NCIT:C17234	oral cavity	UBERON:0000167	Adult	NCIT:C49685	27	27	27	No	Paolo_Manghi	Healthy	NCIT:C115935	MoBio	101	101	SRR1519052	5759396629	57023729	26336637	IlluminaHiSeq	Male	NCIT:C20197	NA	NA	Yes	cMD	2025-07-13 16:10:43.046834
Castro-NallarE_2015	ES_209	ES_209	Schizophrenia	NCIT:C3362	Study Control	NCIT_C142703	United States	NCIT:C17234	oral cavity	UBERON:0000167	Adult	NCIT:C49685	28	28	28	No	Paolo_Manghi	Healthy	NCIT:C115935	MoBio	101	101	SRR1519055	7462779708	73888908	26336637	IlluminaHiSeq	Male	NCIT:C20197	NA	NA	Yes	cMD	2025-07-13 16:10:43.046834
Castro-NallarE_2015	ES_210	ES_210	Schizophrenia	NCIT:C3362	Study Control	NCIT_C142703	United States	NCIT:C17234	oral cavity	UBERON:0000167	Adult	NCIT:C49685	28	28	28	No	Paolo_Manghi	Healthy	NCIT:C115935	MoBio	101	101	SRR1519056	4117605471	40768371	26336637	IlluminaHiSeq	Male	NCIT:C20197	NA	NA	Yes	cMD	2025-07-13 16:10:43.046834
Castro-NallarE_2015	ES_211	ES_211	Schizophrenia	NCIT:C3362	Study Control	NCIT_C142703	United States	NCIT:C17234	oral cavity	UBERON:0000167	Adult	NCIT:C49685	31	31	31	No	Paolo_Manghi	Healthy	NCIT:C115935	MoBio	101	101	SRR1519057	3814507501	37767401	26336637	IlluminaHiSeq	Male	NCIT:C20197	NA	NA	Yes	cMD	2025-07-13 16:10:43.046834
